OSM Industry Intel • Spring 2026 Science Just Found the Cellular “Toxic Waste Leak” Behind Inflammaging. Here Is the Supplement Angle. A 2025 review pulls together a striking discovery: aging immune cells lose the ability to take out their own cellular trash, then leak mitochondrial DNA that the body mistakes for a viral invasion. The […]
Learn More
OSM Industry Intel • Spring 2026 Muscle Is Not Just for Lifting. It Is an Endocrine Organ, and That Changes the Whole Supplement Pitch. A comprehensive June 2026 review reframes skeletal muscle as a context-sensitive signaling organ that pumps out chemical messengers called myokines, talking directly to the liver, bone, brain, and fat. The opportunity […]
Learn More
OSM Industry Intel • Spring 2026 A Trace Mineral Just Became the Most Interesting Story in Brain Aging. And One Specific Form Steals the Show. A landmark 2025 study in Nature found that one mineral, and only one, was selectively depleted in the brains of people with cognitive decline: lithium. The plot twist involves amyloid […]
Learn More
OSM Industry Intel • 2026 The Apigenin Story Just Got More Interesting: A Common Flavonoid That Raises Cellular NAD+ A peer-reviewed study shows the plant flavonoid apigenin inhibits CD38, the enzyme that quietly burns through your NAD+ supply. For brands building longevity and metabolic SKUs, this is a mechanism worth understanding. NAD+ has been having […]
Learn More
OSM Industry Intel • Spring 2026 Your Customers’ Mouthwash Might Be Raising Their Blood Pressure. That Is a Supplement Opportunity. A review in the Journal of Dental Research lays out how bacteria on the back of the tongue convert dietary nitrate into the raw material for nitric oxide, and how killing those bacteria removes up […]
Learn More
OSM Industry Intel • Spring 2026 Vitamin D Might Be a Circadian Clock Ingredient, Not Just a Bone Health One A new review in the International Journal of Molecular Sciences lays out the case that vitamin D helps regulate the body’s biological clock, with implications for sleep, mood, and metabolic health. Here is what it […]
Learn More
OSM Industry Intel • Spring 2026 Liposomal Glutathione Just Crushed Plain Glutathione in a Head-to-Head Study. Here Is What Brands Should Do About It. A new study in the British Journal of Nutrition shows liposomal glutathione delivered 6x higher plasma concentration, nearly 2x cellular uptake, and 100% wound-healing closure versus 59.8% for the plain form. […]
Learn More
OSM Industry Intel • Spring 2026 American Elderberry Juice Just Posted a Signal for Cognitive Flexibility in Mild Cognitive Impairment A new randomized clinical trial in Antioxidants shows daily elderberry juice consumption improved cognitive flexibility speed in older adults with mild cognitive impairment after six months. Here is what supplement brands should be paying attention […]
Learn More
Low-Dose Melatonin and the Climacteric: What a New Shift-Worker Trial Means for Brands Building Women’s Wellness Supplements A fresh randomized controlled trial in nurses gives supplement brands a useful data point for the women’s wellness shelf. Here’s what formulators, product managers, and contract manufacturing partners should actually take away. If you spend any time in […]
Learn More
OSM Industry Intel • Spring 2026 The Phospholipid Shift: Why Your Liposomal “Carrier” Is Now Your Second Active Ingredient New market data shows phosphatidylcholine is being repositioned from delivery material to functional co-active. Here is what that means for pricing, positioning, and your next product label. If you manufacture or sell a liposomal supplement, you […]
Learn More